Garrod Association

The recommendation to establish a permanent national Canadian body to coordinate the management of inherited metabolic disorders emerged from a federally sponsored meeting convened in Ottawa on September 24, 1982. This meeting brought together key clinical, laboratory, and policy stakeholders, reflecting a growing recognition of the need for coordinated national oversight, standardized care, and equitable access to services for individuals affected by these rare conditions across Canada.

The steering committee tasked with advancing this initiative included Joe Clarke, Charles Scriver, Philip Banister (representing Health and Welfare Canada), James Haworth, and Marcia Sharpe (Executive Director of the Canadian Dietetic Association). This group reflected a deliberate integration of clinical, scientific, nutritional, and policy expertise, underscoring the inherently multidisciplinary nature of metabolic care.

Building on this foundation, representatives from 16 centres across Canada delivering care for individuals with inborn errors of metabolism were subsequently appointed. Through a structured and collaborative process, by-laws were established, governance structures formalized, and an Executive Council elected. The organization adopted the name Canadian Association of Centers for the Management of Hereditary Metabolic Disorders / Association Canadienne des Centres de Traitement pour les Maladies Métaboliques Héréditaires, and became informally known as the “Garrod Association,” a designation that both acknowledged historical roots and symbolized a shared national identity. The founding Executive Council consisted of Joe Clarke (Chair), Claude Laberge (Vice-Chair), and James Haworth (Secretary–Treasurer). In 2020, the Association became incorporated under the name “Garrod Association” as a nonprofit organization.

Collectively, these developments marked a pivotal step in the evolution of a coordinated national framework for metabolic medicine in Canada, laying the groundwork for subsequent advances in clinical care, collaborative research, and health system integration.

Over time, the Garrod Association has fostered formal collaborations with key national and international organizations, including the Western Group of Investigators of Inborn Errors of Metabolism, the Canadian Paediatric Society, the Canadian Dietetic Association, the Canadian Society for Metabolic Diseases, and Canadian Organization for Rare Disorders (CORD). Partnerships have expanded to include the Canadian College of Medical Geneticists (CCMG) and the Society for Inherited Metabolic Disorders (SIMD).

Members of the Garrod Association have maintained an active presence in international leadership, serving on the boards of the Society for the Study of Inborn Errors of Metabolism (SSIEM) and SIMD. Through these roles, they have contributed substantively to the development of clinical practice guidelines, the evaluation and advancement of neonatal screening programs, and major national initiatives such as the National PKU Collaborative Study and the National Registry of Inherited Metabolic Diseases. In addition, members have led and informed national manpower and needs assessment surveys, helping to shape workforce planning and service delivery models across Canada. Collectively, these collaborative and leadership activities underscore the Association’s central role in advancing metabolic medicine at both national and international levels.